715 related articles for article (PubMed ID: 2865873)
21. [Influence of interval training on the physical capacity and peripheral circulation in patients with intermittent claudication].
Cachovan M; Marées H; Kunitsch G
Z Kardiol; 1976 Jan; 65(1):54-67. PubMed ID: 1246905
[TBL] [Abstract][Full Text] [Related]
22. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Nederfors T
Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
[TBL] [Abstract][Full Text] [Related]
23. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Silke B; Nelson GI; Ahuja RC; Taylor SH
Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
[TBL] [Abstract][Full Text] [Related]
24. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
25. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
26. Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker, labetalol.
Novo S; Abrignani MG; Sapienza ND; Barbagallo M; Pinto A; Di Maria GU; Mistretta A; Strano A
Int Angiol; 1992; 11(2):137-41. PubMed ID: 1402218
[TBL] [Abstract][Full Text] [Related]
27. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
[TBL] [Abstract][Full Text] [Related]
28. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
Klieber M; Resch F
Wien Klin Wochenschr; 1986 Feb; 98(3):70-3. PubMed ID: 2938341
[TBL] [Abstract][Full Text] [Related]
29. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
Yonga GO; Oyuga HW; Njeru EK
East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
[TBL] [Abstract][Full Text] [Related]
30. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca D; Da Silva A
Cochrane Database Syst Rev; 2008 Oct; (4):CD005508. PubMed ID: 18843692
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of non-invasive haemodynamic parameters in patients with intermittent claudication subjected to physical training.
Binaghi F; Fronteddu PF; Carboni MR; Onnis A; Astara C; Pitzus F
Int Angiol; 1990; 9(4):251-5. PubMed ID: 2099957
[TBL] [Abstract][Full Text] [Related]
32. The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication.
Boström PA; Janzon L; Ohlsson O; Westergren A
Angiology; 1986 Mar; 37(3 Pt 1):149-53. PubMed ID: 3706817
[TBL] [Abstract][Full Text] [Related]
33. [Intermittent claudication and beta-blockaders. An unfortunate combination?].
Andreassen AK; Gullestad L; Bjørnerheim R; Forfang K; Kjekshus J
Tidsskr Nor Laegeforen; 1995 Feb; 115(6):725-8. PubMed ID: 7900137
[TBL] [Abstract][Full Text] [Related]
34. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
[TBL] [Abstract][Full Text] [Related]
35. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
36. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
[TBL] [Abstract][Full Text] [Related]
37. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
van Baak MA; Böhm RO; Arends BG; van Hooff ME; Rahn KH
Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
[TBL] [Abstract][Full Text] [Related]
38. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease.
Hiatt WR; Stoll S; Nies AS
Circulation; 1985 Dec; 72(6):1226-31. PubMed ID: 2866047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
